Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.
Researchers from New York University have uncovered that cancer cells also work together to source nutrients from their ...
21h
AZoLifeSciences on MSNZinc-Carrying Proteins Activate Proton Pump Inhibitors in Neutral EnvironmentsAcid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate ...
Cholesterol is an important part of your body’s health, but too much of the wrong kind can lead to serious problems like ...
11h
The Healthy on MSNOTC Medication Mistakes: Doctors Advise You To Avoid Doing TheseJust because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...
The recent subzero temperatures have forced me to hide inside more than I normally do. So, to combat cabin fever, I have taken a plunge into the crate beneath my ...
14h
News Medical on MSNAI-driven discovery unveils TNIK inhibition as anti-aging strategyA groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative anti-aging strategy.
Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results